TARDBP and Alzheimer disease: We found that the levels high-molecular-weight Aβ species of AD patients with hyperphosphorylated TDP-43 (n = 3) were lower and their levels of Aβ oligomers were higher than those of AD patients but without TDP-43 pathology (n = 5).